Valuation: West Pharmaceutical Services, Inc.

Market Cap 24.49B 21.26B 19.82B 18.21B 34.44B 2,329B 34.82B 234B 91.36B 1,164B 91.95B 89.94B 3,858B P/E 2026 *
40.6x
P/E 2027 * 35.3x
Enterprise Value 23.98B 20.82B 19.42B 17.84B 33.73B 2,281B 34.1B 229B 89.49B 1,140B 90.06B 88.09B 3,779B EV / Sales 2026 *
7.11x
EV / Sales 2027 * 6.54x
Free-Float
92.89%
Yield 2026 *
0.26%
Yield 2027 * 0.28%
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-23
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Change 5-day change 1-year change 3-year change Capi.($)
-11.68%-5.12% - - 24.49B
-1.55%-1.69%-18.83%-2.03% 185B
-0.55%-0.78%-3.84%+2.57% 111B
-0.68%-4.16%+4.30%+65.26% 60B
+2.63%+4.85%+48.14%+59.49% 53.9B
-0.05%+2.27%-4.91%-37.18% 46.9B
+3.88%+3.78% - - 34.22B
-0.42%+16.15%+14.02%-27.75% 32.95B
+0.09%+1.09%+1.93%+3.03% 22.67B
+0.50%+3.29%-9.38%+5.02% 21.75B
Average +0.25%+4.91%+3.93%+8.55% 63.19B
Weighted average by Cap. -0.12%+3.68%-1.86%+8.51%

Financials

2026 *2027 *
Net sales 3.37B 2.93B 2.73B 2.51B 4.75B 321B 4.8B 32.21B 12.59B 160B 12.67B 12.39B 532B 3.59B 3.11B 2.9B 2.67B 5.05B 341B 5.1B 34.24B 13.38B 171B 13.47B 13.18B 565B
Net income 615M 534M 498M 457M 864M 58.46B 874M 5.87B 2.29B 29.22B 2.31B 2.26B 96.83B 701M 609M 568M 522M 986M 66.7B 997M 6.69B 2.62B 33.34B 2.63B 2.58B 110B
Net Debt -503M -437M -407M -374M -708M -47.87B -716M -4.8B -1.88B -23.93B -1.89B -1.85B -79.29B -1.04B -902M -841M -773M -1.46B -98.84B -1.48B -9.92B -3.88B -49.41B -3.9B -3.82B -164B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Trader
Investor
Global
Quality
ESG MSCI
AA